International journal of laboratory hematology · 2025
Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gurumurthy Gerard, Lemma Mikias, Reynolds Lianna, Grainger John, Thachil Jecko
Аннотация
BACKGROUND: Coagulation screening, consisting of prothrombin time (PT) and activated partial prothrombin time (aPTT), is routinely performed in paediatrics to identify bleeding disorders or guide peri-procedural management. We evaluated the trends in utilisation and diagnostic yield of PT and aPTT testing as part of coagulation screening in a tertiary paediatric centre.
METHODS: All PT and aPTT samples received from June to September 2024 were analysed. Total requests, sample rejection rates, abnormal result patterns (isolated PT, isolated APTT, combined), and clinical correlations were recorded. Laboratory cutoffs were PT > 12.5 s and APTT > 30.0 s. Youden's Index determined cutoffs associated with inherited bleeding disorders.
RESULTS: A total of 2808 coagulation profiles from 1207 patients were received, with 15.7% (442/2808) rejected in 268 patients. Of these, 31.7% (85/268) of patients were not re-tested. Among valid requests, 17.0% (402/2366) were abnormal (128 isolated APTT, 173 isolated PT, 101 combined). In a subgroup of 337 randomly selected patients, 28.8% (97/337) had deranged results, leading to 12 new haematological and 34 acute diagnoses. Youden's index determined isolated APTT > 31.4 s associated with inherited disorders (AUC > 0.8). The same was not identified with isolated PT (PT > 13.0 s, AUC < 0.6).
CONCLUSION: A substantial proportion of samples received are rejected, and some abnormal results remain unaddressed. Most abnormal findings are clinically significant, particularly when APTT > 33.1 s. There is scope to refine utilisation in paediatric practice.
METHODS: All PT and aPTT samples received from June to September 2024 were analysed. Total requests, sample rejection rates, abnormal result patterns (isolated PT, isolated APTT, combined), and clinical correlations were recorded. Laboratory cutoffs were PT > 12.5 s and APTT > 30.0 s. Youden's Index determined cutoffs associated with inherited bleeding disorders.
RESULTS: A total of 2808 coagulation profiles from 1207 patients were received, with 15.7% (442/2808) rejected in 268 patients. Of these, 31.7% (85/268) of patients were not re-tested. Among valid requests, 17.0% (402/2366) were abnormal (128 isolated APTT, 173 isolated PT, 101 combined). In a subgroup of 337 randomly selected patients, 28.8% (97/337) had deranged results, leading to 12 new haematological and 34 acute diagnoses. Youden's index determined isolated APTT > 31.4 s associated with inherited disorders (AUC > 0.8). The same was not identified with isolated PT (PT > 13.0 s, AUC < 0.6).
CONCLUSION: A substantial proportion of samples received are rejected, and some abnormal results remain unaddressed. Most abnormal findings are clinically significant, particularly when APTT > 33.1 s. There is scope to refine utilisation in paediatric practice.